Add BrightSurf on Google Email

American College of Cardiology


First-of-its-kind study in endothelial stem cells finds exposure to flavored e-cigarette liquids, e-cigarette use exacerbates cell dysfunction

A new study found that exposure to flavored e-cigarette liquids and e-cigarette use exacerbate endothelial cell dysfunction, a key risk factor for heart disease. The researchers observed pro-inflammatory markers and toxic effects on cells from various e-liquids.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateMay 27, 2019

Demand growing for CV specialists trained to treat heart disease in cancer patients

The number of cardiologists trained in cardio-oncology is not meeting the growing needs of cancer survivors, who are aging and developing co-morbid cardiovascular disease. Limited training programs and resources are emerging to address this need, highlighting the importance of collaboration between cardiologists and oncologists.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateApr 29, 2019

Preschool health program successful in instilling heart healthy habits

A new study published in the Journal of the American College of Cardiology found that a preschool health program significantly increased healthy habit awareness among children from an underserved community. The program resulted in a 2.2-fold higher score on overall knowledge, attitudes and habits towards a healthy lifestyle.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateApr 22, 2019

Two-drug combos using popular calcium channel blocker show superiority in lowering BP

A large randomized controlled trial found that two frontline two-drug combinations including amlodipine significantly reduced blood pressure levels more than a third combination without amlodipine. The study, conducted in sub-Saharan Africa, showed that nearly half of adults have high blood pressure, often receiving ineffective treatment.

SourceAmerican College of Cardiology·JournalNew England Journal of Medicine·DateMar 18, 2019

Pure omega-3 prescription drug markedly reduces first, repeat and total CV events

A new study shows that a 4 gram dose of icosapent ethyl significantly reduces the occurrence of ischemic events, including heart attacks, strokes, and related deaths. The drug also prevents subsequent cardiovascular events and may be a cost-effective way to prevent CV complications in patients with elevated triglycerides.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateMar 18, 2019

Medical bills financially burden almost half of cardiovascular disease patients

A study published in the Journal of the American College of Cardiology found that 45.1% of adult atherosclerotic cardiovascular disease (ASCVD) patients experience financial hardship due to medical bills. Insured and uninsured individuals, particularly those with lower incomes, are disproportionately affected.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateFeb 11, 2019